skip to main content
Idioma:
Refinado por: Nome da Publicação: Clinical Cancer Research remover assunto: Female remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA -Mutated Breast and Gynecologic Cancers
A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA -Mutated Breast and Gynecologic Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA -Mutated Breast and Gynecologic Cancers

Banerji, Udai ; Dean, Emma J ; Pérez-Fidalgo, J Alejandro ; Batist, Gerald ; Bedard, Philippe L ; You, Benoit ; Westin, Shannon N ; Kabos, Peter ; Garrett, Michelle D ; Tall, Mathew ; Ambrose, Helen ; Barrett, J Carl ; Carr, T Hedley ; Cheung, S Y Amy ; Corcoran, Claire ; Cullberg, Marie ; Davies, Barry R ; de Bruin, Elza C ; Elvin, Paul ; Foxley, Andrew ; Lawrence, Peter ; Lindemann, Justin P O ; Maudsley, Rhiannon ; Pass, Martin ; Rowlands, Vicky ; Rugman, Paul ; Schiavon, Gaia ; Yates, James ; Schellens, Jan H M

Clinical cancer research, 2018-05, Vol.24 (9), p.2050-2059 [Periódico revisado por pares]

United States: American Association for Cancer Research Inc

Texto completo disponível

Citações Citado por
2
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

Jhaveri, Komal L ; Bellet, Meritxell ; Turner, Nicholas C ; Loi, Sherene ; Bardia, Aditya ; Boni, Valentina ; Sohn, Joohyuk ; Neilan, Tomas G ; Villanueva-Vázquez, Rafael ; Kabos, Peter ; García-Estévez, Laura ; López-Miranda, Elena ; Pérez-Fidalgo, J Alejandro ; Pérez-García, Jose M ; Yu, Jiajie ; Fredrickson, Jill ; Moore, Heather M ; Chang, Ching-Wei ; Bond, John W ; Eng-Wong, Jennifer ; Gates, Mary R ; Lim, Elgene

Clinical cancer research, 2024-02, Vol.30 (4), p.754-OF13 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.